NCT02669706View on ClinicalTrials.gov

Intravenous Pentamidine for Pneumocystis Jirovecii Pneumonia

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

June 30, 2016

Conditions
Hematologic Malignancy
Interventions
DRUG

Pentamidine

Pentamidine is an antimicrobial medication given for prevention and treatment of Pneumocystis pneumonia (PJP) caused by Pneumocystis jirovecii

Trial Locations (1)

60612

University of Illinois Hospital and Health Sciences System, Chicago

All Listed Sponsors
lead

University of Illinois at Chicago

OTHER

NCT02669706 - Intravenous Pentamidine for Pneumocystis Jirovecii Pneumonia | Biotech Hunter | Biotech Hunter